Issue Information.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 605, doi. 10.1002/jcph.1435
- Publication type:
- Article
Works in Journal of Clinical Pharmacology, 2019, Vol 59, Issue 5
Results: 15
1
2
Running Out of Time: Facilitating Off Label Approval in Cancer Treatment.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
3
4β‐Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 611, doi. 10.1002/jcph.1391
- By:
- Publication type:
- Article
4
Population Pharmacokinetic Analyses and Model Validation of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 763, doi. 10.1002/jcph.1370
- By:
- Publication type:
- Article
5
Population Pharmacokinetics and Exposure‐Response Analyses for CPX‐351 in Patients With Hematologic Malignancies.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 748, doi. 10.1002/jcph.1366
- By:
- Publication type:
- Article
6
Physiologically Based Modeling Approach to Predict Dopamine D2 Receptor Occupancy of Antipsychotics in Brain: Translation From Rat to Human.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 731, doi. 10.1002/jcph.1365
- By:
- Publication type:
- Article
7
A Phase 1 Randomized Study of Single Intravenous Infusions of the Novel Nitroxyl Donor BMS‐986231 in Healthy Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 717, doi. 10.1002/jcph.1364
- By:
- Publication type:
- Article
8
Development of a Subcutaneous Fixed‐Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose‐Finding Study.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 702, doi. 10.1002/jcph.1362
- By:
- Publication type:
- Article
9
Pharmacokinetics, Pharmacodynamics, and Safety of E6011, a Novel Humanized Antifractalkine (CX3CL1) Monoclonal Antibody: A Randomized, Double‐Blind, Placebo‐Controlled Single‐Ascending‐Dose Study.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 688, doi. 10.1002/jcph.1361
- By:
- Publication type:
- Article
10
Accelerating Drug Development in Pediatric Oncology With the Clinical Pharmacology Storehouse.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 625, doi. 10.1002/jcph.1359
- By:
- Publication type:
- Article
11
Pharmacokinetics, Safety, and Tolerability of Single‐Dose Intravenous Moxifloxacin in Pediatric Patients: Dose Optimization in a Phase 1 Study.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 654, doi. 10.1002/jcph.1358
- By:
- Publication type:
- Article
12
Population Pharmacokinetic Analysis of Decitabine in Pediatric Patients With Acute Myeloid Leukemia.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 668, doi. 10.1002/jcph.1357
- By:
- Publication type:
- Article
13
Simplification of Imipenem Dosing by Removal of Weight‐Based Adjustments.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 646, doi. 10.1002/jcph.1356
- By:
- Publication type:
- Article
14
Safety, Tolerability, and Pharmacodynamics of Intrathecal Injection of Recombinant Human HGF (KP‐100) in Subjects With Amyotrophic Lateral Sclerosis: A Phase I Trial.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 677, doi. 10.1002/jcph.1355
- By:
- Publication type:
- Article
15
Accurate Prediction of Initial Busulfan Exposure Using a Test Dose With 2‐ and 6‐Hour Blood Sampling in Adult Patients Receiving a Twice‐Daily Intravenous Busulfan‐Based Conditioning Regimen.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 638, doi. 10.1002/jcph.1354
- By:
- Publication type:
- Article